Oncology Medications

Zytiga - Prostate Cancer Medication

ZYTIGA® (abiraterone acetate)

Physicians + Prescribers: Additional clinical information for your patients can be found on the Zytiga for Health Care Professionals website. 


ZYTIGA in combination with prednisone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).


The recommended dose of ZYTIGA is 1,000 mg (four 250-mg tablets) administered orally once daily on an empty stomach along with prednisone 5 mg taken orally twice daily.


ZYTIGA patients in need of financial assistance can rely on our dedicated patient advocate team, whose sole focus is helping patients afford sustained access to the drug therapies they need.

Contact Us Today

Simply refer your Zytiga prescriptions to Onco360 to experience the industry-leading service and support our oncology focus provides patients and physicians. Our dedicated Oncology Pharmacy staff will provide exceptional service, help manage side-effects, support compliance, and connect patients in need to financial assistance.



Fax a prescription to 877-662-6355. Order Forms


Call 877-662-6633.


e-Prescribe to Onco360 in Louisville, KY 40223, or NPI# 1437577988 under the retail tab in your EMR/EHR or standalone e-prescribing application.

(Note: Onco360 only accepts faxed, telephoned, or e-prescribed prescription drug orders from qualifying prescribers. Patients may only submit original prescription drug orders obtained from their prescribing healthcare practitioner.)